- Home
- ADAG vs DMA Comparison
ADAG vs DMA Comparison
Compare ADAG & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- DMA
- Stock Information
- Founded
- ADAG 2011
- DMA 2011
- Country
- ADAG China
- DMA United States
- Employees
- ADAG N/A
- DMA N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- DMA Trusts Except Educational Religious and Charitable
- Sector
- ADAG Health Care
- DMA Finance
- Exchange
- ADAG Nasdaq
- DMA Nasdaq
- Market Cap
- ADAG 85.9M
- DMA 77.0M
- IPO Year
- ADAG 2021
- DMA N/A
- Fundamental
- Price
- ADAG $1.84
- DMA $8.59
- Analyst Decision
- ADAG Strong Buy
- DMA
- Analyst Count
- ADAG 1
- DMA 0
- Target Price
- ADAG $5.00
- DMA N/A
- AVG Volume (30 Days)
- ADAG 24.0K
- DMA 34.6K
- Earning Date
- ADAG 03-09-2025
- DMA 01-01-0001
- Dividend Yield
- ADAG N/A
- DMA 2.04%
- EPS Growth
- ADAG N/A
- DMA N/A
- EPS
- ADAG N/A
- DMA N/A
- Revenue
- ADAG $815,746.00
- DMA N/A
- Revenue This Year
- ADAG N/A
- DMA N/A
- Revenue Next Year
- ADAG $2.70
- DMA N/A
- P/E Ratio
- ADAG N/A
- DMA N/A
- Revenue Growth
- ADAG N/A
- DMA N/A
- 52 Week Low
- ADAG $1.74
- DMA $4.78
- 52 Week High
- ADAG $4.38
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- ADAG 40.33
- DMA 48.73
- Support Level
- ADAG $1.76
- DMA $8.45
- Resistance Level
- ADAG $2.07
- DMA $8.64
- Average True Range (ATR)
- ADAG 0.14
- DMA 0.12
- MACD
- ADAG -0.00
- DMA 0.02
- Stochastic Oscillator
- ADAG 23.53
- DMA 84.37
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.